Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Evaluation of Immune Recovery Following Autologous Hematopoietic Cell Transplantation in HIV-Related Lymphoma: Results of the BMT CTN 0803/AMC 071 Trial

Blood (2016) 128 (22): 1346.

https://doi.org/10.1182/blood.V128.22.1346.1346

Published: 2016

Journal Articles

A Multivariate Clinical and Economic Model for Predicting Risk-Based Costs of Care for Acute Leukemia (AL) Patients (Pts) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Joseph C. Alvarnas, MD, Guido Marcucci, MD, Ann Vanderplas, MS, Eileen P. Smith, MD, Joyce L. Murata-Collins, PhD, Alexandra M. Levine, MD, Joyce Niland, MD, Joycelynne Palmer, PhD, Tsai Ni-Chun, Rebecca Ottesen, Michael Rabin, Zara Dzagikian, Shery Azimi, Joseph Rosenthal, MD MS, Harlan Levine, MD, Stephen J. Forman, MD

Blood (2016) 128 (22): 3547.

https://doi.org/10.1182/blood.V128.22.3547.3547

Published: 2016

Journal Articles

AIDS-lymphoma (ARL): one more step along the way

Alexandra M. Levine

Blood (2013) 122 (19): 3244–3246.

https://doi.org/10.1182/blood-2013-09-526350

Published: 2013

Journal Articles

HIV-associated lymphoma

Alexandra M. Levine

Blood (2010) 115 (15): 2986–2987.

https://doi.org/10.1182/blood-2010-01-262717

Published: 2010

Journal Articles

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

Blood (2010) 115 (15): 3008–3016.

https://doi.org/10.1182/blood-2009-08-231613

Published: 2010

Journal Articles

Stem cell transplantation in AIDS-lymphoma

Alexandra M. Levine

Blood (2009) 114 (7): 1284–1285.

https://doi.org/10.1182/blood-2009-06-224204

Published: 2009

Journal Articles

A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics, and Efficacy of ABT-263 in Subjects with Refractory or Relapsed Lymphoid Malignancies.

Wyndham H. Wilson, Anil Tulpule, Alexandra M. Levine, Kieron Dunleavy, Andrew P. Krivoshik, Anne E. Hagey, Margaret Shovlin, Melanie A. Gloria, Renee Greco, Hao Xiong, Yi-Lin Chiu, Steven W. Elmore, Owen A. O’Connor

Blood (2007) 110 (11): 1371.

https://doi.org/10.1182/blood.V110.11.1371.1371

Published: 2007

Journal Articles

Hodgkin lymphoma: to the HAART of the matter

Alexandra M. Levine

Blood (2006) 108 (12): 3630.

https://doi.org/10.1182/blood-2006-09-047498

Published: 2006

Journal Articles

Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia

Dan Douer, Henry Yampolsky, Lewis J. Cohen, Kristy Watkins, Alexandra M. Levine, Antonia P. Periclou, Vassilios I. Avramis

Blood (2006) 109 (7): 2744–2750.

https://doi.org/10.1182/blood-2006-07-035006

Published: 2006

Journal Articles

Phase I Study of the [Cu, Zn] Superoxide Dismutase (SOD1) Inhibitor ATN-224 (Bis-Choline Tetrathiomolybdate) in Patients (pts) with Advanced Hematologic Malignancies.

James R. Berenson, MD, Ralph Vincent Boccia, MD, Asad Bashey, MD PhD, Alexandra M. Levine, MD, Omer N. Koc, MD, Jennifer A. Callahan, Andrew P. Mazar, PhD, Steven D. Reich, MD

Blood (2006) 108 (11): 2593.

https://doi.org/10.1182/blood.V108.11.2593.2593

Published: 2006

Journal Articles

Treatment of Non-APL Acute Myelogenous Leukemia with Intravenous Arsenic Trioxide Plus Ascorbic Acid.

Dan Douer, MD, Kristy Watkins, R.N., Robert Louie, PhramD, Ilene Ceil Weitz, M.D., Ann Mohrbacher, M.D., Lisa Mark, P.A., Alexandra M. Levine, M.D.

Blood (2006) 108 (11): 1959.

https://doi.org/10.1182/blood.V108.11.1959.1959

Published: 2006

Journal Articles

The Pharmacokinetics, Safety and Lack of Antibody Production from Multiple Doses of Intravenous Pegylated Asparaginase in Adults with Newly Diagnosed Acute Lymphoblastic Leukemia.

Dan Douer, MD, Kristy Watkins, R.N., Niyati Nathwani, M.D., Alexandra M. Levine, M.D., Prakash N. Tiwari, M.D., Vassilos I. Avramis, Ph.D.

Blood (2006) 108 (11): 1873.

https://doi.org/10.1182/blood.V108.11.1873.1873

Published: 2006

Journal Articles

Phase I Study of Noscapine for Patients with Non-Hodgkin’s Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy.

Anil Tulpule, MD, Alexandra M. Levine, MD, Nancy E. Berman, RN, BSN, Lynne Smith, PhD, Alan Auerbach, Dan Douer, MD

Blood (2005) 106 (11): 3341.

https://doi.org/10.1182/blood.V106.11.3341.3341

Published: 2005

Journal Articles

A Phase 2 Study of the Thrombospondin-Mimetic Peptide ABT-510 in Patients with Refractory Lymphoma.

Alexandra M. Levine, MD, Lee Schwartzberg, MD, Sonali Smith, MD, Robert Belt, Raymond Knight, Dawn Carlson, Richard Hippensteel, Brad Kahl

Blood (2005) 106 (11): 1493.

https://doi.org/10.1182/blood.V106.11.1493.1493

Published: 2005

Journal Articles

Results of a Pilot Trial of Fludarabine, Mitoxantrone and Rituxan in Mantle Cell Lymphoma.

Alexandra M. Levine, MD, Anil Tulpule, MD, Lynne Smith, PhD, Byron M. Espina, AB, Ann F. Mohrbacher, MD, Donald I. Feinstein, MD

Blood (2005) 106 (11): 945.

https://doi.org/10.1182/blood.V106.11.945.945

Published: 2005

Journal Articles

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010

Lawrence D. Kaplan, Jeannette Y. Lee, Richard F. Ambinder, Joseph A. Sparano, Ethel Cesarman, Amy Chadburn, Alexandra M. Levine, David T. Scadden

Blood (2005) 106 (5): 1538–1543.

https://doi.org/10.1182/blood-2005-04-1437

Published: 2005

Journal Articles

Treatment of Anemia with Aranesp® (Darbepoetin-alfa) Given Once Every Two Weeks in HIV Seropositive Patients.

Anil Tulpule, M.D., Dharshika Dharmapala, Pamela Burian, PA-C, Byron M. Espina, Gerald Jayne, Shelly George, M.D., Alexandra M. Levine, M.D.

Blood (2004) 104 (11): 3108.

https://doi.org/10.1182/blood.V104.11.3108.3108

Published: 2004

Journal Articles

Development of Prothrombotic Repertoire with Progressive HIV Disease: Data from the Women’s Interagency HIV Study (WIHS).

Alexandra M. Levine, M.D., Cheryl Vigen, Jay Gravink, Howard A. Liebman, M.D.

Blood (2004) 104 (11): 1057.

https://doi.org/10.1182/blood.V104.11.1057.1057

Published: 2004

Journal Articles

Thrombocytopenia Is a Strong Predictor of All-Cause and AIDS-Specific Mortality in Women with HIV: The Women’s Interagency HIV Study.

C. Leigh Pearce, Ph.D., Wendy J. Mack, Ph.D., Alexandra M. Levine, M.D., Jay Gravink, M.A., Mardge H. Cohen, M.D., Edward L. Machtinger, M.D., Kathryn Anastos, M.D., Michael J. Silverberg, Ph.D., Mary A. Young, M.D., Howard Minkoff, M.D., D. Heather Watts, M.D.

Blood (2004) 104 (11): 2068.

https://doi.org/10.1182/blood.V104.11.2068.2068

Published: 2004

Journal Articles

Treatment of Acute Myelogenous Leukemia (non-APL) with Intravenous Trisenox® (Arsenic Trioxide) and Ascorbic Acid: Preliminary Results.

Dan Douer, MD, Kristy Watkins, RN, Robert Louie, PharmD, Ilene Weitz, MD, Ann Mohrbacher, MD, Alexandra M. Levine, MD

Blood (2004) 104 (11): 1815.

https://doi.org/10.1182/blood.V104.11.1815.1815

Published: 2004

NARROW

Evaluation of Immune Recovery Following Autologous Hematopoietic Cell Transplantation in HIV-Related Lymphoma: Results of the BMT CTN 0803/AMC 071 Trial

A Multivariate Clinical and Economic Model for Predicting Risk-Based Costs of Care for Acute Leukemia (AL) Patients (Pts) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

AIDS-lymphoma (ARL): one more step along the way

HIV-associated lymphoma

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

Stem cell transplantation in AIDS-lymphoma

A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics, and Efficacy of ABT-263 in Subjects with Refractory or Relapsed Lymphoid Malignancies.

Hodgkin lymphoma: to the HAART of the matter

Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia

Phase I Study of the [Cu, Zn] Superoxide Dismutase (SOD1) Inhibitor ATN-224 (Bis-Choline Tetrathiomolybdate) in Patients (pts) with Advanced Hematologic Malignancies.

Treatment of Non-APL Acute Myelogenous Leukemia with Intravenous Arsenic Trioxide Plus Ascorbic Acid.

The Pharmacokinetics, Safety and Lack of Antibody Production from Multiple Doses of Intravenous Pegylated Asparaginase in Adults with Newly Diagnosed Acute Lymphoblastic Leukemia.

Phase I Study of Noscapine for Patients with Non-Hodgkin’s Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy.

A Phase 2 Study of the Thrombospondin-Mimetic Peptide ABT-510 in Patients with Refractory Lymphoma.

Results of a Pilot Trial of Fludarabine, Mitoxantrone and Rituxan in Mantle Cell Lymphoma.

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010

Treatment of Anemia with Aranesp® (Darbepoetin-alfa) Given Once Every Two Weeks in HIV Seropositive Patients.

Development of Prothrombotic Repertoire with Progressive HIV Disease: Data from the Women’s Interagency HIV Study (WIHS).

Thrombocytopenia Is a Strong Predictor of All-Cause and AIDS-Specific Mortality in Women with HIV: The Women’s Interagency HIV Study.

Treatment of Acute Myelogenous Leukemia (non-APL) with Intravenous Trisenox® (Arsenic Trioxide) and Ascorbic Acid: Preliminary Results.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only